Saakshi Medtech and Panels Limited (NSE:SAAKSHI)
India · Delayed Price · Currency is INR 262.00
+6.55 (2.56%)
Jun 16, 2026, 11:16 AM IST
NSE:SAAKSHI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,155 | 924.31 | 1,219 | 1,221 | 915.78 |
Other Revenue | - | - | - | - | 0 |
| 1,155 | 924.31 | 1,219 | 1,221 | 915.78 | |
Revenue Growth (YoY) | 24.96% | -24.14% | -0.17% | 33.28% | 53.21% |
Cost of Revenue | 642.32 | 579.53 | 778.73 | 801.47 | 608.35 |
Gross Profit | 512.74 | 344.78 | 439.78 | 419.11 | 307.43 |
Selling, General & Admin | 187.12 | 198 | 191.26 | 166.54 | 118.78 |
Other Operating Expenses | 103.43 | 43.34 | 51.26 | 43.79 | 32.22 |
Operating Expenses | 337.97 | 280.24 | 281.01 | 236.87 | 168.21 |
Operating Income | 174.77 | 64.54 | 158.77 | 182.24 | 139.22 |
Interest Expense | -13.48 | -2.11 | -15.07 | -12.61 | -13.44 |
Interest & Investment Income | - | 4.59 | 6.11 | 1.03 | 0.86 |
Currency Exchange Gain (Loss) | - | 0.81 | 0.45 | -2.96 | - |
Other Non Operating Income (Expenses) | 5.38 | -1.95 | -0.81 | -1.8 | -0.45 |
EBT Excluding Unusual Items | 166.67 | 65.89 | 149.44 | 165.9 | 126.18 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.28 |
Pretax Income | 166.67 | 65.89 | 149.44 | 165.9 | 126.47 |
Income Tax Expense | 43.77 | 18.79 | 36.37 | 42.14 | 32.71 |
Net Income | 122.9 | 47.1 | 113.06 | 123.77 | 93.76 |
Net Income to Common | 122.9 | 47.1 | 113.06 | 123.77 | 93.76 |
Net Income Growth | 160.94% | -58.34% | -8.65% | 32.01% | 326.02% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 13 | 13 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 13 | 13 |
Shares Change (YoY) | 0.01% | - | 35.82% | - | - |
EPS (Basic) | 6.96 | 2.67 | 6.40 | 9.52 | 7.21 |
EPS (Diluted) | 6.96 | 2.67 | 6.40 | 9.52 | 7.21 |
EPS Growth | 160.92% | -58.32% | -32.77% | 32.00% | 326.02% |
Free Cash Flow | -80.88 | -121.78 | -242.02 | -1.14 | 51.07 |
Free Cash Flow Per Share | -4.58 | -6.90 | -13.71 | -0.09 | 3.93 |
Gross Margin | 44.39% | 37.30% | 36.09% | 34.34% | 33.57% |
Operating Margin | 15.13% | 6.98% | 13.03% | 14.93% | 15.20% |
Profit Margin | 10.64% | 5.10% | 9.28% | 10.14% | 10.24% |
Free Cash Flow Margin | -7.00% | -13.18% | -19.86% | -0.09% | 5.58% |
EBITDA | 222.19 | 98.19 | 197.25 | 208.77 | 156.44 |
EBITDA Margin | 19.24% | 10.62% | 16.19% | 17.10% | 17.08% |
D&A For EBITDA | 47.42 | 33.65 | 38.48 | 26.54 | 17.22 |
EBIT | 174.77 | 64.54 | 158.77 | 182.24 | 139.22 |
EBIT Margin | 15.13% | 6.98% | 13.03% | 14.93% | 15.20% |
Effective Tax Rate | 26.26% | 28.52% | 24.34% | 25.40% | 25.86% |
Revenue as Reported | 1,160 | 930.03 | 1,226 | 1,222 | 916.94 |